Acquisition of Phenobarbital, Cephalosporin, Etc. and Medications for Medical Aids-pharmacy.

• Country: Argentina
• Summary: Acquisition of Phenobarbital, Cephalosporin, Etc. and Medications for Medical Aids-pharmacy.
• ART Ref No: 120255769
• Deadline: 11 Jun 2025
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: ARS 35579500.00
• Notice Type: Tender
• Document Ref. No.: 417-0838-LPU25
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Phenobarbital. Model: 100 mg, injectable, in ampoule x 2 ml, cephalosporin of 4th generation. Model: 600 mg, in Amprola bottle, a hormone liberating of hyphaffysical human gonadotrophins (LHRH). Model: 100 µg/2 ml injectable, lyophilized, in ampoule, subcutaneous/intravenous use, isotonic polyhelectrolytic solution. Model: composition every 100 ml. Sodium, chloride 0.526 g + sodium gluconate 0.502 g + potassium, chloride 0.037 g + sodium, trihydrate acetate 0.367 g + water to see more, paracetamol. Model: 500 mg, 10 mg x ml, intravenous injectable, in a blister bottle of x 50 ml., Sterile syringe. Model: polypropylene, capacity: 3 ml. Containing 80 U.I. of liophilized lithium heparin, balanced calcium and closing cap., Brivacetam as required by the applicant distribution. Model: 50 mg in tablets, ruffinamide. Model: 400 mg, in covered tablet, phosphate potassium solution. Model: With 3 mmol of phosphorus and 4.4 meq of potassium per milliliter, in ampoule x 10 ml, intravenous, sterile and apirogenic use, aspartic insulin. Model: Ultra -grape action, in pre -cleded syringe, commercial novorapid reference, loperamide hydrochloride. Model ...
• Documents:

 Tender Notice